Evidence map›Paper›PMID 23535824›Full record

ArticleHuman molecular genetics2013

Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression.

Zsofia Kote-Jarai, Edward J Saunders, Daniel A Leongamornlert, Malgorzata Tymrakiewicz, Tokhir Dadaev, Sarah Jugurnauth-Little, Helen Ross-Adams, Ali Amin Al Olama, Sara Benlloch, Silvia Halim and 74 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 78 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 6 pooled it
14.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 6 syntheses or guidelines pooled it, 110 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Article
  9. Article
  10. fSuSiE enables fine-mapping of QTLs from genome-scale molecular profiles.bioRxiv : the preprint server for biology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Polymorphic tandem DNA repeats activate the human telomerase reverse transcriptase gene.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

84 authors at 20 institutions in 12 countries.

Zsofia Kote-JaraiThe Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK. zsofia.kote-jarai@icr.ac.uk
Edward J Saunders
Daniel A Leongamornlert
Malgorzata Tymrakiewicz
Tokhir Dadaev
Sarah Jugurnauth-Little
Helen Ross-Adams
Ali Amin Al Olama
Sara Benlloch
Silvia Halim
Roslin Russell
Roslin Russel
Alison M Dunning
Craig Luccarini
Joe Dennis
David E Neal
Freddie C Hamdy
Jenny L Donovan
Ken Muir
Graham G Giles
Gianluca Severi
Fredrik Wiklund
Henrik Gronberg
Christopher A Haiman
Fredrick Schumacher
Brian E Henderson
Loic Le Marchand
Sara Lindstrom
Peter Kraft
David J Hunter
Susan Gapstur
Stephen Chanock
Sonja I Berndt
Demetrius Albanes
Gerald Andriole
Johanna Schleutker
Maren Weischer
Federico Canzian
Elio Riboli
Tim J Key
Ruth C Travis
Daniele Campa
Sue A Ingles
Esther M John
Richard B Hayes
Paul Pharoah
Kay-Tee Khaw
Janet L Stanford
Elaine A Ostrander
Lisa B Signorello
Stephen N Thibodeau
Dan Schaid
Christiane Maier
Walther Vogel
Adam S Kibel
Cezary Cybulski
Jan Lubinski
Lisa Cannon-Albright
Hermann Brenner
Jong Y Park
Radka Kaneva
Jyotsna Batra
Amanda Spurdle
Judith A Clements
Manuel R Teixeira
Koveela Govindasami
Michelle Guy
Rosemary A Wilkinson
Emma J Sawyer
Angela Morgan
Ed Dicks
Caroline Baynes
Don Conroy
Stig E Bojesen
Rudolf Kaaks
Daniel Vincent
François Bacot
Daniel C Tessier
COGS-CRUK GWAS-ELLIPSE (Part of GAME-ON) Initiative
UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology
UK ProtecT Study Collaborators
PRACTICAL Consortium
Douglas F Easton
Rosalind A Eeles
Institute of Cancer Research · GBUniversity of Cambridge · GBCancer Research UK · GBUniversity of Southern California · USHarvard University · USMcGill University · CANational Cancer Institute · USCancer Prevention Institute of California · USHeidelberg University · DEKarolinska Institutet · SEMayo Clinic in Arizona · USPomeranian Medical University · PLQueensland University of Technology · AUUniversity Hospital Ulm · DEUniversity of Oxford · GBAmerican Cancer Society · USCancer Council Victoria · AUCopenhagen University Hospital · DKDana-Farber Brigham Cancer Center · USFred Hutch Cancer Center · US

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI John L. Cleveland · 1998 to 2026
$93.5M
Southern Community Cohort StudyR01CA092447 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BLOT, WILLIAM J., ZHENG, WEI · 2001 to 2015
$74.0M
Finding Genes for Human Prostate CancerZIAHG200325 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI OSTRANDER, ELAINE · 2009 to 2021
$17.7M
Epidemiological and Clinical Translational Studies Post Genome-Wide AssociationU19CA148537 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI EASTON, DOUGLAS FREDERICK, EELES, ROSALIND · 2010 to 2014
$10.4M
Cancer Research UK 10118Cancer Research UK 10119Cancer Research UK 10124Cancer Research UK 11022Cancer Research UK 14136Cancer Research UK 15007Cancer Research UK 16561Cancer Research UK 16565Cancer Research UK C1287/A10118Cancer Research UK C16913/A6135Cancer Research UK C5047/A10692Cancer Research UK C5047/A3354Cancer Research UK C5047/A7357Medical Research Council G0401527Medical Research Council G0900871Medical Research Council G1000143NCI NIH HHS 1 U19 CA 148537-01NCI NIH HHS P30 CA076292NCI NIH HHS R01 CA092447
6 · The paper itself

Abstract

Associations between single nucleotide polymorphisms (SNPs) at 5p15 and multiple cancer types have been reported. We have previously shown evidence for a strong association between prostate cancer (PrCa) risk and rs2242652 at 5p15, intronic in the telomerase reverse transcriptase (TERT) gene that encodes TERT. To comprehensively evaluate the association between genetic variation across this region and PrCa, we performed a fine-mapping analysis by genotyping 134 SNPs using a custom Illumina iSelect array or Sequenom MassArray iPlex, followed by imputation of 1094 SNPs in 22 301 PrCa cases and 22 320 controls in The PRACTICAL consortium. Multiple stepwise logistic regression analysis identified four signals in the promoter or intronic regions of TERT that independently associated with PrCa risk. Gene expression analysis of normal prostate tissue showed evidence that SNPs within one of these regions also associated with TERT expression, providing a potential mechanism for predisposition to disease.

Indexed as

Genetic Predisposition to DiseaseAdultCase-Control StudiesChromosome MappingChromosomes, Human, Pair 5GenotypeHumansLinkage DisequilibriumMalePolymorphism, Single NucleotidePromoter Regions, GeneticProstatic NeoplasmsTelomeraseTelomeraseTERT protein, human

Identifiers

PMID23535824
PMCPMC3658165
OpenAlexW2152915426

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.